Clinical Trials
62 trialsOUTREACH
Mina Alpha Limited
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Refinement and Validation of a Diagnostic Model (GAMAD) for Early Detection of Hepatocellular Carcinoma
Singlera Genomics Inc.
To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307
Eutilex
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
ImmVira Pharma Co. Ltd
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Panolos Bioscience
GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma
Suzhou Kintor Pharmaceutical Inc,
HCC
Sinocelltech Ltd.
Clinical Research on Dynamic Monitoring MRD Via Plasma ctDNA After Systemic Therapy of Hepatocellular Carcinoma
Singlera Genomics Inc.
A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
Shanghai Ming Ju Biotechnology Co., Ltd.
BC3402 in Combination With Durvalumab in Patients With Advanced Hepatocellular Carcinoma
Biocity Biopharmaceutics Co., Ltd.
NWRD06 DNA Plasmid for HCC After Radical Resection
Newish Technology (Beijing) Co., Ltd.
NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection
Newish Technology (Beijing) Co., Ltd.
OASES
Gongwin Biopharm Co., Ltd.
Polyvinyl Alcohol Embolization Microspheres
Shanghai Huihe Medical Technology Co., Ltd
SynOV1.1 Intratumoral Injection Study
Beijing Syngentech Co., Ltd.
GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescence PCR Method)
Wuhan Ammunition Life-tech Co., Ltd
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Provectus Pharmaceuticals
Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers
Genoscience Pharma
A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients
Shanghai Henlius Biotech
DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria
Hyperfusion
Study of HX008 in Combination With Bevacizumab or Lenvatinib for the Treatment of Advanced Hepatocellular Carcinoma (HCC)
Taizhou Hanzhong biomedical co. LTD
Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies
Shenzhen BinDeBio Ltd.
A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma.
Innovent Biologics (Suzhou) Co. Ltd.
PIONEER
SpeciCare
Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors
Curegenix Inc.
A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy
Ivy Life Sciences, Co., Ltd
AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma
Shanghai AbelZeta Ltd.
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Shenzhen BinDeBio Ltd.
A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Study of EOC317 in Chinese Patients With Advanced Solid Tumors
Taizhou EOC Pharma Co., Ltd.
Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma
Evolve Biologics
Hepko-V5
Immunitor LLC
PERSEE
Mauna Kea Technologies
Circulating Tumor DNA Exposure in Peripheral Blood
Quantgene Inc.
A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation
Lion TCR Pte. Ltd.
Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma
Oncolys BioPharma Inc
Expanding Phase III Study of Tyroserleutide for Injection
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
PixelShine vs. Iterative Reconstruction (IR) Processing of CT Images
AlgoMedica, Inc.
A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART)
Shanghai GeneChem Co., Ltd.
A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA
Chuan An Biotechnology Co., Ltd.
Clemizole HCl for Subjects With Hepatocellular Carcinoma
Eiger Group International, Inc.
CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy
Shanghai GeneChem Co., Ltd.
ALTER0802
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Dendritic Killer Cell-based Immunotherapy for Solid Tumors
FullHope Biomedical Co., Ltd.
Feasibility of Electromagnetic Acoustic Imaging of Liver Tumours
Enhanced Medical
DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma
Shenzhen Hornetcorn Bio-technology Company, LTD